The Brain Malignancies Steering Committee (BMSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult and pediatric brain cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The BMSC's membership comprises NCTN group representatives, NCI-funded consortia representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-Chairs
Anita Mahajan, M.D.
Johns Hopkins University
Patrick Yung Chih Wen, M.D.
Mass General Brigham
Members
Manmeet Ahluwalia, M.D., FACP
Cleveland Clinic
David F. Arons, J.D.
National Brain Tumor Society
Daniel Barboriak, M.D.
Duke University Medical Center
Mitchel S. Berger, M.D.
University of California, San Francisco
Priscilla Brastianos, M.D.
Massachusetts General Hospital
Nicholas A. Butowski, M.D.
University of California, San Francisco
Ira Dunkel, M.D.
Memorial Sloan Kettering Cancer Center
William Edenfield, M.D., M.S.
Prisma Health Cancer Institute
Maryam Fouladi, M.D.
Cincinnati Children's Hospital Medical Center
Susan Geyer, Ph.D.
Mayo Clinic
John W. Glod, M.D.
National Cancer Institute, Center for Cancer Research
Vinai Gondi, M.D.
Northwestern University Feinberg School of Medicine
Amanda Haddock
Dragon Master Foundation
Lindsay Kilburn, M.D.
Children's National Hospital
Andrew B. Lassman, M.D.
Columbia University
Sarah Leary, M.D., M.S.
Seattle Children's Hospital
Linda M. Liau, M.D., Ph.D.
University of California, Los Angeles
Michael Lim, M.D.
Stanford University
Christine Lu-Emerson, M.D.
Maine Medical Center
Bhupinder S. Mann, M.B.B.S.
National Cancer Institute
Annette Marie Molinaro, Ph.D.
University of California, San Francisco
Arzu Onar-Thomas, Ph.D.
St. Jude Children's Research Hospital
Marshall Pitz, M.D.
CancerCare Manitoba
Jana Portnow, M.D.
City of Hope Comprehensive Cancer Center
Alyssa Reddy, M.D.
University of California, San Francisco
David Roberge, M.D.
Centre Hospitalier de l'Universit de Montr al
Nathan J. Robison, M.D., M.S.
Children's Hospital Los Angeles
Larry V. Rubinstein, Ph.D.
National Cancer Institute
Jann N. Sarkaria, M.D.
Mayo Clinic
David Schiff, M.D.
University of Virginia
Malcolm Smith, M.D., Ph.D.
National Cancer Institute
Erik Sulman, M.D., Ph.D.
Duke Cancer Center
Tony J. Wang, M.D.
Columbia University Herbert Irving Comprehensive Cancer Center
Jing Wu, M.D., Ph.D.
National Cancer Institute
NCI CCCT Program Director
Abdul Tawab Amiri, Ph.D.
atawab@mail.nih.gov